Proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy (2023–2024)
Kidney360 · 2025-10 · 6 (10) · 1798-1809
DOI: 10.34067/kid.0000000951 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney360, online erschienen am 08.08.2025. Verfasst von William Beaubien-Souligny und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. Hauptthemen laut MEDLINE: Acute Kidney Injury, Continuous Renal Replacement Therapy, Renal Replacement Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
In this second installment of the proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy (CRRT) Academy, we focus on the topic of transitions of care in acute renal replacement therapy (RRT). Although we have accumulated data from thousands of critically ill patients with AKI randomized to different strategies for RRT initiation, no trial data exist to guide de-escalation of RRT in the intensive care unit. However, for survivors of severe AKI whose kidney function does not recovery rapidly enough to allow for liberation directly from CRRT, successful de-escalation of care requires the transition from CRRT to intermittent RRT modalities. These transition periods must be carefully navigated since they can be a source of complications, such as failure to transition or intradialytic hypotension, which are in turn associated with an increased risk of mortality and reduced odds of kidney recovery. In this review, we focus on the critical factors to consider during de-escalation of RRT care, with a focus on modality transition, the role of volume status in guiding the approach to de-escalation of RRT, and the vital importance of careful dosing of drugs, especially antimicrobial agents, during this transitional period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada.
- Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky.
- Divisions of Nephrology and Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico.
- Division of Nephrology, Department of Medicine, Albany Medical College, Albany, New York.
- Divisions of Pulmonary, Allergy, Critical Care, and Sleep Medicine and Renal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, New York.
- Division of Nephrology, Department of Medicine, Institute for Critical Care Medicine at Mount Sinai Hospital, New York, New York.
ORCID-Profile: William Beaubien-Souligny, Melissa Thompson Bastin, J Pedro Teixeira, Jorge Cerda, Michael J Connor, Amanda Dijanic Zeidman, Pranav S Garimella, Luis Juncos, Arnaldo Lopez-Ruiz, Ravindra Mehta, Lilia Rizo-Topete, Samuel A Silver, J Ricardo Da Silva, Rajesh Speer, Anitha Vijayan, Catherine Wells, Keith Wille, Lenar Yessayan, Ashita Tolwani, Javier A Neyra
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Beaubien-Souligny, W., Thompson Bastin, M., Teixeira, J. P., Cerda, J., Connor, M. J., Dijanic Zeidman, A., Garimella, P. S., Juncos, L., Lopez-Ruiz, A., Mehta, R., Reis, T., Rizo-Topete, L., Silver, S. A., Da Silva, J. R., Speer, R., Vijayan, A., Wells, C., Wille, K., Yessayan, L., …, & Neyra, J. A. (2025). Proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy (2023–2024). Kidney360, 6(10), 1798-1809. https://doi.org/10.34067/kid.0000000951
Vancouver
Beaubien-Souligny W, Thompson Bastin M, Teixeira JP, Cerda J, Connor MJ, Dijanic Zeidman A, et al. Proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy (2023–2024). Kidney360. 2025;6(10):1798-1809. doi:10.34067/kid.0000000951
BibTeX
@article{BeaubienSouligny2025,
author = {Beaubien-Souligny, William and Thompson Bastin, Melissa and Teixeira, J Pedro and Cerda, Jorge and Connor, Michael J and Dijanic Zeidman, Amanda and Garimella, Pranav S and Juncos, Luis and Lopez-Ruiz, Arnaldo and Mehta, Ravindra and Reis, Thiago and Rizo-Topete, Lilia and Silver, Samuel A and Da Silva, J Ricardo and Speer, Rajesh and Vijayan, Anitha and Wells, Catherine and Wille, Keith and Yessayan, Lenar and Tolwani, Ashita and Neyra, Javier A},
title = {Proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy (2023–2024)},
journal = {Kidney360},
year = {2025},
volume = {6},
number = {10},
pages = {1798--1809},
doi = {10.34067/kid.0000000951}
}
EUVIMED